Browse Category

NYSE:CLX 4 November 2025 - 30 January 2026

Procter & Gamble stock rises as Wall Street turns defensive — what traders watch next

Procter & Gamble stock rises as Wall Street turns defensive — what traders watch next

Procter & Gamble shares rose 1.1% to $151.58 Friday afternoon as investors moved into consumer-staples stocks amid inflation concerns and policy uncertainty. The S&P 500 fell 0.4% while the XLP staples ETF gained 1.2%. Senate obstacles raised the risk of a partial U.S. government shutdown before the midnight funding deadline. Investors await the Feb. 6 jobs report and further policy signals.
Clorox stock (CLX) ends week higher: what to watch on dividend, Glad shift, ERP fallout

Clorox stock (CLX) ends week higher: what to watch on dividend, Glad shift, ERP fallout

Clorox shares closed up 1.9% at $106.19 Friday, outperforming Procter & Gamble and Colgate-Palmolive, but remain 35% below their 52-week high. Clorox will buy Procter & Gamble’s 20% stake in the Glad joint venture at its Jan. 31 termination. The company expects ERP-related disruptions to cut fiscal 2026 earnings by about 90 cents per share. Clorox shares trade ex-dividend Jan. 28.
Palantir’s Shocking Reinvention: From Secretive Spy Tech to $400B Cult Lifestyle Brand

Palantir’s ‘Otherworldly’ Earnings & Wegovy Deal Buzz Spark After-Hours Stock Fireworks

Palantir shares rose after Q3 results beat estimates and the company raised its outlook for a third straight quarter, citing surging AI platform demand. Hims & Hers stock jumped 7% post-market as it entered talks to offer Novo Nordisk’s Wegovy, despite mixed earnings. Sarepta plunged over 20% after a key Duchenne drug trial failed its main goal. Sanmina soared 18% on a strong earnings beat and guidance far above Wall Street forecasts.
Go toTop